NASDAQ:DARA (DARA) (DARA) Stock Price, News & Analysis → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free DARA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range$0.32▼$0.3352-Week Range N/AVolume13,850 shsAverage Volume118,843 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (DARA) alerts: Email Address Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit About (DARA) Stock (NASDAQ:DARA)DARA BioSciences Inc is specialty pharmaceutical company based in the United States. The Company’s primary focus is on the commercialization of oncology treatment and oncology supportive care pharmaceutical products, including Soltamox, an oral solution of tamoxifen citrate; cancer support therapeutics, including Gelclair, indicated for the treatment of oral mucositis and Bionect, for the management of irritation of the skin as well as first and second degree burns, and Three Mission Pharmacal products, including Ferralet 90 (for anemia), Binosto (alendronate sodium effervescent tablet indicated for the treatment of osteoporosis) and Aquoral (for cancer related dry mouth). The Company has a clinical development asset, KRN5500, which is a Phase II product candidate targeted for treating cancer patients with painful treatment-refractory chronic chemotherapy induced peripheral neuropathy. The Company is a subsidiary of Midatech Pharma Plc.Read More Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit DARA Stock News HeadlinesMay 4, 2024 | msn.comSandara Park jams to 'In or Out,' 'Festival' while touring Pagsanjan FallsMay 3, 2024 | markets.businessinsider.comEstée Lauder: Hold Rating Assigned Amid Slower Growth and Market PressuresMay 4, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. May 2, 2024 | msn.comIntroducing legislation that would restrict cell phone use in Pennsylvania schoolsMay 2, 2024 | yahoo.comPrincess Beatrice Is a Proud Mom as She Shares 2-Year-Old Daughter's Favorite HobbyMay 2, 2024 | msn.comSinton Trail opening on south side of Ellston StreetMay 2, 2024 | yahoo.comTruck theft suspect arrested after police chaseMay 2, 2024 | msn.comIn Florida, Kamala Harris puts spotlight on abortion politicsMay 4, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. May 1, 2024 | msn.comMaharashtra State Armwrestling Championship 2024: Dara Singh Handa reigns supremeMay 1, 2024 | yahoo.comFollowing an Honor Flight, a mission, and a life, completedMay 1, 2024 | markets.businessinsider.comEmploy Announces New Chief Product OfficerMay 1, 2024 | msn.comPueblo’s Team Up to Clean Up offering free dump dayMay 1, 2024 | yahoo.com“DEVASTATED: Colorado’s Fentanyl Disaster” premiereMay 1, 2024 | msn.comFinally, Some Good Dating-App NewsApril 30, 2024 | msn.comAward-Winning Detroit Free Press Food Critic Lyndsay Green Earns a James Beard NominationApril 30, 2024 | msn.comFreep dining critic Lyndsay Green nominated for James Beard awardApril 30, 2024 | msn.comBumble revamps the 'first move' and other featuresApril 30, 2024 | msn.comLA’s Booming Croissant Scene Has a New Pastry Powerhouse From Two Hotshot BakersApril 30, 2024 | bbc.co.ukFive massive reasons you should join Dara and Ed on their Great Big AdventureApril 29, 2024 | msn.com“They Found Our Sex Drawer and Squirted Lube Everywhere”: 5 Stories of Playdates from HellApril 29, 2024 | forbes.com5 Quality Cocktail Mixers For Effortless EntertainingApril 27, 2024 | msn.comMan Utd 1-1 Burnley: What Kompany saidApril 26, 2024 | msn.comFrom Zendaya to Margot: ‘method dressing’ is an actor’s album eraApril 26, 2024 | msn.comPrincess Beatrice’s ex-boyfriend Paolo Liuzzo dead of drug overdose in Miami hotel room: reportApril 25, 2024 | msn.comMother of Princess Beatrice's stepson shares rare videos of fun family life in LondonApril 23, 2024 | msn.comThe extraordinary and ancient secret places hidden under TurkeySee More Headlines Receive DARA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (DARA) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/02/2015Today5/03/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:DARA CUSIPN/A CIK919745 Webwww.darabiosciences.com Phone+1-816-9147027FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report DARA Stock Analysis - Frequently Asked Questions How were (DARA)'s earnings last quarter? (DARA) (NASDAQ:DARA) issued its earnings results on Monday, November, 2nd. The specialty pharmaceutical company reported ($0.14) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.14). The specialty pharmaceutical company earned $1.18 million during the quarter, compared to analyst estimates of $0.83 million. What other stocks do shareholders of (DARA) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (DARA) investors own include Castleton Technology (CTP), Richland Resources Ltd (RLD.L) (RLD), Thor Energy (THR), Global Invacom Group (GINV), Legendary Investments (LEG), iPass (IPAS), Aeterna Zentaris (AEZS), Clontarf Energy (CLON) and MoSys (MOSY). This page (NASDAQ:DARA) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCFW: 234x GainWeiss RatingsCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (DARA) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.